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Abstract 
Background: To evaluate whether there is an association between single nucleotide polymorphisms in magnesium-
permeable TRPM6 ion channel and development of meningomyelocele (MMC). Therefore, we examined a total of 150 
children with MMC, along with age- and gender-matched controls. DNA collected from whole blood was analyzed 
for the presence of two polymorphisms, rs2274924 (A > G; K1579E; Leu1579Glu) and rs3750425 (G > A; Val1393Ile), in 
TRPM6. Serum Mg2+ and calcium levels were also examined.
Results: A statistically significant difference in the distribution of rs2274924 genotypes (p = 0.049) was observed 
between the groups. Decreases in the AA genotype, and increases in the AG heterozygous genotype were also 
detected in the study group. The distribution of polymorphisms in the rs3750425 genotype and alleles was not statis-
tically different between groups. Serum Mg2+ levels were lower in the GG genotype of rs3750425 compared with the 
GA and AA genotypes (p = 0.003).
Conclusions: A statistically significant difference in rs3750425 genotypes was observed between the patients with 
MMC and the controls, which corresponded to lower serum Mg2+ concentrations in these patients. Taken together, 
these results suggest that genetic variations in the Mg2+-permeable TRPM6 ion channel may play a role in the eti-
opathogenesis of MMC during embryonic development.
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Background
Neural tube defects (NTDs) occur during embryogenic 
period when the neural tube lefts uncovered to close nor-
mally and neural tissue exposed to the intrauterine envi-
ronment. It affects about 0.1–0.4 % in worldwide, 0.3 % in 
Turkey (Mandiracioğlu et al. 2004; van Rooij et al. 2003) 
and 2.6/1000 in East Anatolia region of Turkey in live 
births (Saraç et  al. 2007). Meningomyelocele (MMC) is 
a nonlethal but severely disabling form of NTD (Shutleff 
and Graaf 2001). Etiology of MMC remains poorly under-
stood, most likely driven by a combination of genetic and 
environmental factors (Miao et al. 2016; Au et al. 2010). 
Genetic factors may contribute up to 70 % of NTD preva-
lence based on epidemiological evidences to date (Leck 
1974; Copp and Greene 2010; Bassuk and Kibar 2009). 
Maternal health problems, including inadequate nutri-
tion have also been shown to affect neural tube closure 
through a variety of mechanisms (Copp et al. 2013).
Magnesium (Mg2+) is the second most abundant cation 
in cell and is essential for all stages of life, from the early 
embryo to adult. Regulation of cellular as well as whole 
body Mg2+ homeostasis is critical for human health. 
Although the concentration of Mg2+ in the extracellular 
environment can vary significantly, the total intracellular 
Mg2+ concentration is actively maintained within a rela-
tively narrow range (14–20  mM) via tight (Komiya and 
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Runnels 2015; Romani 2011). This responsibility largely 
achives to Mg2+ transporters and ion channels. Transient 
receptor potential cation channel, subfamily M, member 
6 (TRPM6; 602014), located on chromosome 9q21.13, 
plays a central role in the regulation of Mg2+ homeostasis 
via absorption and reabsorption of Mg2+ from the small 
intestines and kidneys, respectively (Song et  al. 2009; 
Hruby et al. 2013; Groenestege et al. 2006; Schlingmann 
et al. 2005).
Homozygous TRPM6 knockout embryos died by 
E12.5 and exhibited neural tube closure defects (Wal-
der et al. 2002). The expression pattern of TRPM6 dur-
ing embryogenesis demonstrated a significant increase 
at E10, suggesting TRPM6 is also temporally required 
for early development. Heterozygous TRPM6 knock-
out mice exhibited mild hypomagnesemia (Walder 
et  al. 2002; Woudenberg-Vrenken et  al. 2011). Muta-
tions in TRPM6 occur in the rare autosomal-recessive 
disease hypomagnesemia with secondary hypocalcemia 
(HSH) in human (Schlingmann et  al. 2002). As indi-
cated in many studies, hypomagnesemia in null mice 
is sufficient to induce NTDs, as well as developmental 
disorders of the bones (Walder et  al. 2009; Chubanov 
and Gudermann 2014). Proper Mg2+ levels are also of 
particular importance to pregnant women, with defi-
ciencies associated with premature birth and intrau-
terine growth retardation, along with increases in both 
mortality and morbidity during the embryonic period. 
Embryotoxic and teratogenic effects of Mg2+ have also 
been reported in animal models. Lower serum Mg2+ 
levels are strongly associated with skeletal malforma-
tions, osteogenesis imperfecta, and growth retardation 
of the embryo, as well as dysregulation of fetal tem-
perature and sudden infant death (Hurley et  al. 1976; 
Günther et al. 1981).
The fundamental principles underlying TRPM6 
ion channel operation have been described in detail. 
TRPM7, an ion channel permeable to both Ca+ and 
Mg2+, functions via the formation of heterodimers 
with TRPM6 (Günther et  al. 1981). Single nucleotide 
polymorphisms (SNPs) of TRPM6 have been associated 
with diabetes mellitus and serum magnesium level in 
human (Song et al. 2009; Hruby et al. 2013; Walder et al. 
2009). Given these associations, we sought to investi-
gate the role of rs2274924 (A > G; K1579E;Leu1579Glu) 
ve Rs3750425 (G > A Val1393Ile) polymorphisms in 
TRPM6 comparing with the frequency of specific geno-
types and alleles in patients with MMC and healthy con-
trols and the potential correlation between these SNP 
variants and serum Mg2+ and calcium concentrations to 
identify potential functional outcomes associated with 
disease genotypes.
Methods
This case–control study was conducted after obtaining 
approval from the institutional ethics committee (pro-
tocol number 31.01.2013/02/12). Oral and written con-
sent were obtained from all families prior to inclusion in 
this study. A total of 150 patients diagnosed with MMC 
admitted to the outpatient clinics of neurosurgery, pedi-
atric surgery, and pediatrics were enrolled in this study. 
An additional 150 patients admitted to the pediatric 
surgery outpatient clinic with no evidence of abnormal 
sacral spine examination findings were used as a control 
group. The demographic characteristics and clinical his-
tory of each patient were investigated in detail. Evidence 
of consanguineous marriage between parents or earlier 
generations was also noted. Due to the possibility of tera-
togenic effects, maternal use of any drug during the peri-
conceptional period was recorded. Serum calcium and 
Mg2+ levels were assessed using a colorimetric assay.
Isolation of DNA
DNA isolation was performed using the Promega Wiz-
ard® Genomic DNA Isolation Kit according to the man-
ufacturer’s instructions. The DNA concentration was 
measured using a MaestroNano® (MaestroNanodrop; 
Maestrogen, USA), and diluted to 1–10 ng.
Genotyping using TaqMan® probes
SNPs of rs2274924 (A  >  G; K1579E;Leu1579Glu) and 
rs3750425 (G > A; Val1393Ile) in TRPM6 were ana-
lyzed using TaqMan® probes in combination with 
an ABI 7500 Fast Real-Time PCR System (Applied 
Biosystems, Foster City, CA, USA). The genomic 
sequence of rs2274924 was assessed using the 
probe AGTCCTTGAGTATTCTTCTTTTTCT[C/
T]TGACAGTCTCCTGTCTTTGGTTAGC (Assay ID: 
C_16183233_20). Polymorphism at this nucleotide con-
fers an AAG to GAG substitution, resulting in a leucine to 
glutamic acid substitution at residue 1579. For genotyp-
ing, the kit used FAM and VIC florescent dyes for the A 
and G alleles, respectively, as forward and reverse primers. 
The genomic sequence of rs3750425 was assessed using 
the probe TCCACTGATGCCCAGTCAGAGACAA[C/
T]TGGGGTCTGCCCAGTCAGATGAACA (Assay ID: 
C_25943493_20). Polymorphism at this nucleotide con-
fers an ATT to GAG substitution, resulting in a valine to 
isoleucine substitution at residue 1393. For genotyping, 
the kit used FAM and VIC florescent dyes for the A and 
G alleles, respectively, as forward and reverse primers. All 
polymerase chain reaction (PCR) reaction mixtures were 
prepared on ice.
From each sample, we combined 2.5  µL DNA with 
7.5 µL PCR reaction mixture for a final volume of 10 µL. 
Page 3 of 6Saraç et al. SpringerPlus  (2016) 5:1703 
Plates were then covered with optical film, centrifuged, 
and analyzed using a 7500 Fast Real-Time PCR System 
for 40 cycles. The device software was used to identify 
homozygous mutant, heterozygous, and homozygous 
normal genotypes for each allele.
Statistical analysis
Data were analyzed using the IBM Statistical Package for 
the Social Sciences v. 21 (SPSS Inc., Chicago, IL, USA). 
Relationships between parameters were assessed using 
Pearson’s correlation analysis. Distributions of genotype 
and allele frequency were analyzed using a Chi square 
test. The Mann–Whitney U test was used to evaluate 
differences between groups. Data were expressed as the 
mean ± standard deviation. A p value <0.05 was consid-
ered statistically significant.
Results
The study group (n = 150) consisted of 60 female (40 %) 
and 90 (60 %) male patients. The mean age of the study 
group was 3.1  ±  3.22  years (range 1  month–18  years). 
The mean age of the mothers was 28.15  ±  4.71  years 
(range 19–44 years). A detailed list of demographic, clini-
cal, and laboratory findings are presented in Table 1.
 No significant differences in genotype or allele dis-
tributions of TRPM6 rs3750425 polymorphisms were 
evident between the groups (Table 2). In contrast, a sta-
tistically significant difference was observed between 
the study and control groups in terms of the distribu-
tion of the rs2274924 genotype (p =  0.049). Prevalence 
of the AA genotype was markedly decreased in patients 
with MMC, while the heterozygous AG genotype was 
increased. However, no significant difference in the dis-
tribution of rs2274924 alleles was observed between the 
groups (Table 2).
Within the study group, we observed a statistically sig-
nificant difference in serum Mg2+ levels associated with 
rs3750425 genotypes but not for rs2274924 genotype. 
Serum Mg2+ levels were significantly lower in patients 
harboring the rs3750425 GG genotype relative to those 
possessing either the GA or AA genotypes (p  =  0.003; 
Table  3). No differences were observed in relation to 
rs2274924 genotypes.
Discussion
Our statistical finding focused on two coding SNPs in 
TRPM6 in NTD patients. TRPM6 polymorphism may 
contribute to different ways the NTD development, such 
as regulating osteogenesis during embryonic develop-
ment, effecting the maternal serum magnesium level 
in pregnant women and changing in the expression 
level under the influence of estrogen hormone during 
pregnancy.
A limited number of studies have investigated the 
potential links between TRPM6 variations and human 
disease. In our study population, approximately 31.5  % 
are heterozygous for the rare G allele of rs2274924 and 
22 % heterozygous for the allele A of rs3750425. The Hap-
Map studies were shown that population frequencies are 
0.07–0.21 for the rs3750425 A allele (1393 Ile) and 0.15–
0.36 for the rs2274924 G allele (1584Glu) in four ethnic 
groups (Walder et  al. 2009). Song et  al. (2009) provide 
suggestive evidence that two common non-synonymous 
TRPM6 coding region variants, Ile1393Val (rs3750425) 
and Lys1584Glu (rs2274924) polymorphisms, might 
confer susceptibility to type 2 diabetes in women with 
low magnesium intake. However, a follow-up study of 
Romero et al. (2010), Shuen et al. (2009) failed to dupli-
cate these results for rs3750425 and rs2274924. A signifi-
cant association was observed between common variants 
of TRPM6 and hypomagnesemia (Hruby et  al. 2013; 
Meyer et al. 2010), with a specific T allele of rs11144134 
in TRPM6 associated with higher femoral neck and lum-
bar spine BMD (Meyer et  al. 2010). Magnesium-defi-
ciency has been linked to osteoporosis and low BMD in 
observational and animal studies (Alexander et al. 2008). 
Disorders in osteogenesis responsible from inhibition 
of bone matrix mineralization (Semczuk and Semczuk-
Sikora 2001; Durlach 2004; Takaya et al. 2006). The tran-
scripts of canonical TRPM6 channel were also revealed 
in human MG-63, SaOS and U2 OS osteoblast cell lines 
(Abed et al. 2009). These observations show that TRPM6 
may important the control of bone homeostasis during 
embryonic and adulthood. Polymorphic amino acids for 
two polymorphisms investigated in present study are 
located between the coiled region and kinase near the 
C-terminal (Schlingmann et  al. 2004). Although these 
amino acid changes in coiled region of TRPM6 protein 
are improbable responsible for direct regulation of trans-
membrane structures and kinase activity, they may alter 
Table 1 Demographic, clinical, and  laboratory findings 
of each group
MMC Meningomyelocele
Study group Control group
Age (years) 3.1 ± 3.22 9.7 ± 2.21
Female/male 60/90 75/75
History of another baby  
with MMC in the family
18 (11.9 %) –
Consanguinity between parents 41 (27.3 %) 15 (10 %)
History of another baby with  
a congenital anomaly in the family
32 (21.3 %) 10 (6.6 %)
Drug use during pregnancy 25 (16.6 %) 15 (10 %)
Calcium (mg/dL) 9.09 ± 1.24 10.0 ± 1.25
Mg2+ (mg/dL) 1.98 ± 0.62 2.3 ± 0.39
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protein conformation and thus decrease TRPM6 channel 
activity.
Mg2+ deficiency causes or contributes to some abnor-
malities during embrionic development in human and 
rats. The decreased maternal Mg2+ intake because of inad-
equate nutrition and embryonic genetic defects might be 
responsible from Mg2+ deficiency. A maternal Mg2+ intake 
below 378 mg/day has been associated with a twofold to 
threefold higher risk for the neural tube defect, spina 
bifida in offspring, suggesting a pivotal role for Mg2+ not 
just in growth but in morphogenesis as well (Groenen 
et al. 2004). A decrease in basal [Mg2+]i from cord blood 
platelets is associated with small for gestational age (SGA) 
babies in humans (Venu et  al. 2008). Oral Mg2+ sup-
plementation given before the 25th week of gestation is 
also associated with a lower frequency of preterm births, 
a lower frequency of low birth weight, and fewer SGA 
infants compared with placebo (Makrides and Crowther 
2001). Pups of pregnant females fed a Mg2+ deficient diet 
demonstrated an increased incidence of resorptions, gross 
malformation, growth retardation, abnormal fat metabo-
lism, insulin resistance and diabetes (Hurley et  al. 1976; 
Venu et  al. 2008). Despite these apparent links between 
maternal serum Mg2+ levels and some embryonic and 
fetal anomalies, no correlation was found between mater-
nal or neonatal serum Mg2+ levels and MMC (Golalipour 
and Mansourian 2010). These observations are broadly 
consistent with the results presented here, with no signifi-
cantly different neonatal serum Mg2+ or Ca+ levels evident 
between the groups, although lower serum Mg2+ levels 
were detected in patients with GG genotypes in rs3750425 
compared with either the GA or AA variants. As Mg2+ 
homeostasis in the embryo is critically dependent on the 
maternal blood supply, a lack of genetic and biochemi-
cal analysis of maternal serum samples to assess whether 
Mg2+ homeostasis was altered during prenatal develop-
ment was the main limitation of our study.
Recent studies have continued to add to the grow-
ing number of Mg2+ transporters and ion channels 
Table 2 Frequencies of the genotypes and alleles of rs3750425 and rs2274924 polymorphisms in the transient receptor 
potential cation channel, subfamily M, member 6 (TRPM6) gene
GG wild type, GA heterozygous, AA polymorphic allele, AA wild type, AG heterozygous, GG polymorphic allele
Genotypes p value Odds ratio (95 %)
GG GA AA
rs3750425 Polymorphism groups
 Study group 94 53 3 0.14 1.45 (0.88–2.39)
 Control group 103 40 7
Alleles
G A
 Study group 241 59 0.68 1.11 (0.74–1.67)




 Study group 71 66 13 0.049 1.84 (1.13–3)
 Control group 91 46 13
Alleles
A G
 Study group 214 86 0.22 1.27 (0.88–1.83)
 Control group 228 72
Table 3 Mean serum Mg2+ and  Ca+ levels in  patients 
with  meningomyelocele (MMC) according to  their geno-
type
Polymorphism Calcium p value Mg2+ p value
rs3750425 GG 9.2 ± 1.20 0.48 1.51 ± 0.31 0.003
GA 9.0 ± 1.21 2.0 ± 0.34
AA 9.5 ± 1.18 2.1 ± 0.38
rs2274924 AA 9.35 ± 1.17 0.33 1.80 ± 0.41 0.37
AG 9.02 ± 1.15 1.82 ± 0.48
GG 9.30 ± 1.2 1.81 ± 0.42
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involved in Mg2+ homeostasis during embryogenesis. 
The expression pattern of TRPM6 during embryogenesis 
demonstrated a significant increase at E10, suggesting 
TRPM6 is also temporally required for early develop-
ment. Heterozygous TRPM6 knockout mice exhibited 
mild hypomagnesemia (Walder et al. 2002; Woudenberg-
Vrenken et  al. 2011). Interestingly, in one of the stud-
ies dams fed with a high Mg2+ diet slightly suppressed 
the embryonic lethality caused by knockout of TRPM6, 
suggesting that embryonic lethality may in part be due 
to Mg2+ deficiency. However, in the second study by 
Woudenberg-Vreken et al. (2011) a high Mg2+ diet failed 
to rescue the lethality caused by homozygous deletion 
of TRPM6. Rare mutations or polymorphic variants in 
TRPM6, including amino acid substitutions that pre-
vent its heterooligomerization with TRPM7 or changing 
channel activity, may cause the imbalance in intracellular 
magnesium level and likely to contribute the abnormal 
bone development during embryogenesis.
Recent studies have shown that estrogen directly 
increases the transcription of TRPM6, as well as its activ-
ity (Cao et al. 2009); this effect is of particular importance 
during pregnancy, due to the marked increase in mater-
nal estrogen levels. As 90 % of maternal estriol consists 
of fetal precursors, these effects take on added signifi-
cance (Buster et al. 1976). Given the strong evidence that 
estrogen influences TRPM6 synthesis during pregnancy, 
this gene is likely to play an important role in the regula-
tion of Mg2+ homeostasis in both the mother and fetus. 
Genetic variations in TRPM6 may therefore affect intra-
cellular Mg2+ levels during embryonic development, with 
significant implications for fetal development.
Several limitations in present study must be completed 
with further consideration. First, our study had relatively 
small sample size, however, consistency with laboratory 
findings makes our results acceptable. Second, popula-
tion’s etnic diversity may be a concern but imposible to 
clarify our findings, because our populations are racially 
homogeneous, all participant lived in Elazig region. 
Third, althought serum magnesium may be a good indi-
cator for heavy magnesium deficiency, we didn’t per-
formed the measures of extracellular or intracellular 
magnesium status and the patch clamp experiment to 
display the effect on channel activity of studying poly-
morphic variant in TRPM6 gene.
Clinical data show that sufficient magnesium intake 
can partially compensate for the severe magnesium 
deficiency caused by genetic defect in the TRPM6 gene 
(Altıncık et  al. 2016). High magnesium concentrations 
in intestinal tracts may overcome the genetic defects of 
magnesium absorption and independently increase mag-
nesium absorption via the other pathways. Inadequating 
of dietary magnesium intake, the function of TRPM6 in 
active intestinal magnesium absorption and renal reab-
sorption happen very important. Based on these obser-
vations, we strongly recommend checking serum Mg2+ 
values of babies born with MMC. Further studies per-
formed on a large number of patients will be necessary 
to confirm these findings, as well as clarify the etiology of 
MMC, particularly in the context of Mg2+ homeostasis.
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